Abbott Laboratories (NYSE: ABT) reported first quarter 2021 earnings results today.
Sales increased 35.3% year-over-year to $10.5 billion. On an organic basis, sales growth was 32.9%.
On a GAAP basis, net earnings more than doubled to $1.79 billion, or $1.00 per share, compared to the year-ago period. Adjusted EPS jumped 103% to $1.32.
For FY2021, Abbott projects GAAP EPS from continuing operations to be at least $3.74. Adjusted EPS from continuing operations is expected to be at least $5.00.
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
CVX Earnings: Chevron reports lower revenue and profit for Q3 2024
Energy exploration company Chevron Corporation (NYSE: CVX) on Friday announced third-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation dropped to
Key highlights from Exxon Mobil Corporation’s (XOM) Q3 2024 earnings results
Exxon Mobil Corporation (NYSE: XOM) reported its third quarter 2024 earnings results today. Total revenues and other income remained relatively flat at $90 billion compared to the same period a
AAPL Earnings: Apple Q4 2024 sales rise 6% YoY, beat estimates
Apple Inc. (NASDAQ: AAPL) reported an increase in revenues for the fourth quarter of 2024. The top line came in above estimates. The gadget giant generated revenues of $94.9 billion